Results for dasatinib translation from Romanian to English

dasatinib
dasatinib 198/259

mutaţii rezistente la dasatinib
dasatinib resistant mutations

substanţa activă este dasatinib.
the active substance is dasatinib.

sprycel 100 mg comprimate dasatinib
sprycel 100 mg tablets dasatinib

dasatinib 100 mg o dată pe zi 259
dasatinib 100 mg once daily 259

sprycel 100 mg comprimate filmate dasatinib
sprycel 100 mg film-coated tablets dasatinib

sprycel conține substanța activă dasatinib.
sprycel contains the active substance dasatinib.

dasatinib este asociat cu retenţia de fluide.
dasatinib is associated with fluid retention.

ce conţine sprycel substanta activă este dasatinib.
what sprycel contains the active substance is dasatinib.

cu tratament anterior cu imatinib şi dasatinib sau nilotinib
with prior treatment with imatinib and dasatinib or nilotinib

efectul dasatinib asupra spermei este necunoscut (vezi pct.
the effect of dasatinib on sperm is unknown (see section 5.3).

dasatinib şi metaboliţii acestuia sunt puţin excretaţi prin rinichi.
dasatinib and its metabolites are minimally excreted via the kidney.

cyp3a4 este o enzimă majoră responsabilă pentru metabolizarea dasatinib.
cyp3a4 is a major enzyme responsible for the metabolism of dasatinib.

fiecare comprimat filmat conţine dasatinib (ca monohidrat) 20 mg.
each film-coated tablet contains 20 mg dasatinib (as monohydrate).

datele non-clinice demonstrează că solubilitatea dasatinib este dependentă de ph.
non-clinical data demonstrate that the solubility of dasatinib is ph-dependent.

dasatinib, nilotinib, vinblastină şi vincristină, medicamente utilizate pentru tratarea cancerului
dasatinib, nilotinib, vinblastine and vincristine, medicines used to treat cancer

fiecare comprimat filmat conţine dasatinib (sub formă de monohidrat) 100 mg.
each film-coated tablet contains 100 mg dasatinib (as monohydrate).

utilizarea concomitentă a dasatinib şi a unui substrat cyp3a4 poate creşte expunerea la substratul cyp3a4.
concomitant use of dasatinib and a cyp3a4 substrate may increase exposure to the cyp3a4 substrate.

dasatinib, nilotinib, paclitaxel, vinblastină, vincristină, medicamente utilizate pentru tratarea cancerului
dasatinib, nilotinib, paclitaxel, vinblastine, vincristine, medicines used to treat cancer

sprycel 20 mg comprimate filmate sprycel 50 mg comprimate filmate sprycel 70 mg comprimate filmate sprycel 80 mg comprimate filmate sprycel 100 mg comprimate filmate sprycel 140 mg comprimate filmate dasatinib
sprycel 20 mg film-coated tablets sprycel 50 mg film-coated tablets sprycel 70 mg film-coated tablets sprycel 80 mg film-coated tablets sprycel 100 mg film-coated tablets sprycel 140 mg film-coated tablets dasatinib